These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34382119)

  • 1. Prospective Evaluation of an Abbreviated Test Battery to Screen for Neurocognitive Impairment in HIV-Positive Military Members.
    Agan BK; Won SH; Ganesan A; Smith BR; Estupigan C; Maves R; Utz G; Hsieh HC; Tramont E; Nath A; Snow J
    AIDS Behav; 2021 Oct; 25(10):3347-3354. PubMed ID: 34382119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort.
    Moore DJ; Roediger MJ; Eberly LE; Blackstone K; Hale B; Weintrob A; Ganesan A; Agan BK; Letendre SL; Crum-Cianflone NF
    PLoS One; 2012; 7(11):e47310. PubMed ID: 23144815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mobile App to Screen for Neurocognitive Impairment: Preliminary Validation of NeuroScreen Among HIV-Infected South African Adults.
    Robbins RN; Gouse H; Brown HG; Ehlers A; Scott TM; Leu CS; Remien RH; Mellins CA; Joska JA
    JMIR Mhealth Uhealth; 2018 Jan; 6(1):e5. PubMed ID: 29305338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.
    Yechoor N; Towe SL; Robertson KR; Westreich D; Nakasujja N; Meade CS
    J Neurovirol; 2016 Dec; 22(6):808-815. PubMed ID: 27245592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study.
    Pasipanodya EC; Montoya JL; Campbell LM; Hussain MA; Saloner R; Paolillo EM; Jeste DV; Letendre SL; McCutchan JA; Heaton RK; Moore DJ
    Arch Clin Neuropsychol; 2021 Feb; 36(2):151-164. PubMed ID: 31696212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for HIV-associated neurocognitive impairment: Development and validation of an abbreviated neuropsychological test battery for use in South African clinical settings.
    Spies G; Deist M; Suliman S; Seedat S
    Neuropsychology; 2023 Feb; 37(2):166-180. PubMed ID: 36442008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttraumatic Stress Disorder and Neurocognitive Impairment in a U.S. Military Cohort of Persons Living with HIV.
    Deiss R; Campbell CJ; Watson CW; Moore RC; Crum-Cianflone NF; Wang X; Ganesan A; Okulicz LCJ; Letendre S; Maves RC; Moore DJ; Agan BK
    Psychiatry; 2019; 82(3):228-239. PubMed ID: 30925113
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings.
    Chan LG; Ho MJ; Lin YC; Ong Y; Wong CS
    AIDS Res Ther; 2019 Apr; 16(1):9. PubMed ID: 30987670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of neurocognitive deficits in people living with HIV in Sub Saharan Africa: A systematic review.
    Nyamayaro P; Chibanda D; Robbins RN; Hakim J; Gouse H
    Clin Neuropsychol; 2019; 33(sup1):1-26. PubMed ID: 31043112
    [No Abstract]   [Full Text] [Related]  

  • 13. A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen.
    Muñoz-Moreno JA; Prats A; Pérez-Álvarez N; Fumaz CR; Garolera M; Doval E; Negredo E; Ferrer MJ; Clotet B;
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):585-92. PubMed ID: 24135776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?
    Parry S; Zetler S; Kentridge A; Petrak J; Barber T
    AIDS Care; 2017 Oct; 29(10):1275-1279. PubMed ID: 28292203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.
    Robbins RN; Scott TM; Gouse H; Marcotte TD; Rourke SB
    Curr Top Behav Neurosci; 2021; 50():429-478. PubMed ID: 32677005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.
    Kabuba N; Anitha Menon J; Franklin DR; Heaton RK; Hestad KA
    AIDS Behav; 2017 Jun; 21(6):1717-1727. PubMed ID: 27278547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.
    Trunfio M; De Francesco D; Vai D; Medina C; Milesi M; Domini S; Alcantarini C; Imperiale D; Bonora S; Di Perri G; Calcagno A
    AIDS Behav; 2022 Jul; 26(7):2203-2211. PubMed ID: 34982319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.
    Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA
    Clin Infect Dis; 2016 Sep; 63(5):687-693. PubMed ID: 27325690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.
    Royal W; Cherner M; Carr J; Habib AG; Akomolafe A; Abimiku A; Charurat M; Farley J; Oluyemisi A; Mamadu I; Johnson J; Ellis R; McCutchan JA; Grant I; Blattner WA
    J Neurovirol; 2012 Jun; 18(3):191-9. PubMed ID: 22528480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.
    de Almeida SM; Kamat R; Cherner M; Umlauf A; Ribeiro CE; de Pereira AP; Franklin D; Heaton RK; Ellis RJ
    J Acquir Immune Defic Syndr; 2017 Mar; 74(3):332-338. PubMed ID: 27828876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.